Target Price | $3.06 |
Price | $1.36 |
Potential |
125.00%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target InflaRx N.V. 2026 .
The average InflaRx N.V. target price is $3.06.
This is
125.00%
register free of charge
$10.50
672.06%
register free of charge
$2.02
48.53%
register free of charge
|
|
A rating was issued by 14 analysts: 12 Analysts recommend InflaRx N.V. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the InflaRx N.V. stock has an average upside potential 2026 of
125.00%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 0.19 | 0.10 |
171.43% | 49.95% | |
EBITDA Margin | -32,442.11% | -1,511.34% |
56.34% | 95.34% | |
Net Margin | -28,463.16% | -55,950.07% |
60.22% | 96.57% |
9 Analysts have issued a sales forecast InflaRx N.V. 2025 . The average InflaRx N.V. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an InflaRx N.V. EBITDA forecast 2025. The average InflaRx N.V. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $-61.6m | 18.52% |
---|---|---|
2025 |
$-1.4m
97.67%
Unlock
|
2024 | -32,442.11% | 56.34% |
---|---|---|
2025 |
-1,511.34%
95.34%
Unlock
|
9 InflaRx N.V. Analysts have issued a net profit forecast 2025. The average InflaRx N.V. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.92 | -0.79 |
0.00% | 14.13% | |
P/E | negative | |
EV/Sales | 375.50 |
9 Analysts have issued a InflaRx N.V. forecast for earnings per share. The average InflaRx N.V. EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Oppenheimer |
Locked
➜
Locked
|
Locked | May 29 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | May 08 2025 |
Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Mar 26 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 07 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 16 2025 |
Analyst Rating | Date |
---|---|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 29 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
May 08 2025 |
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Apr 29 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 26 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 21 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 07 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 16 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.